Sale of 5,294 shares at $6.0183 per share.
Reporting Person Readnour Robin Shane · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001193125-26-385511 · filed 2026-09-08 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "AN2 Therapeutics, Inc. (ANTX)." Disclosed 2026-09-08. https://desqlong.com/cards/0001193125-26-385511-4 (retrieved 2026-09-26).